What is imaware?
imaware operates a comprehensive diagnostics platform designed to deliver personalized health management and wellness programs. Through customizable at-home and lab testing solutions, the company caters to a diverse clientele, including health and wellness firms, employers, pharmaceutical companies, health systems, and payors. Their platform leverages advanced biomarker capabilities to enable businesses to provide tailored health insights and recommendations, thereby enhancing corporate wellness initiatives and fostering stronger user connections. The company's focus on data-driven solutions and personalization aims to improve health outcomes across its client base.
How much funding has imaware raised?
imaware has raised a total of $15M across 1 funding round:
Angel/Seed
$15M
Angel/Seed (2022): $15M with participation from Naren Shaam, Lakestar, Cherry Ventures, Christian Reber, June Fund, and Lucas von Cranach
Key Investors in imaware
Lakestar
Lakestar is a venture capital firm focused on partnering with visionary tech entrepreneurs across sectors like Deep Tech, Healthcare, and Fintech. They invest from Seed to Growth stages, leveraging their European ecosystem connections to support ambitious founders.
Cherry Ventures
Cherry Ventures is an early-stage venture capital firm based in Europe, founded by experienced entrepreneurs. They invest in startups across various industries, providing capital and operational expertise to founders.
June Fund
June Fund is a global technology investor backed by leading industrial minds, focusing on new paradigms across all stages, from networks to decentralized protocols.
What's next for imaware?
The substantial enterprise-level funding and strategic investment indicate imaware is poised for significant scaling and further development of its diagnostic and wellness platform. This capital infusion will likely fuel expansion into new markets, enhance technological capabilities, and strengthen strategic partnerships. The company's focus on personalized health management and corporate wellness solutions positions it to capitalize on the growing demand for proactive and data-driven healthcare interventions. Future growth may involve deeper integration with healthcare providers and payors, as well as the expansion of its biomarker analysis services to address a wider range of health conditions and wellness goals.
See full imaware company page
